Somatostatin and insulin mediate glucose-inhibited glucagon secretion in the pancreatic α-cell by lowering cAMP

American Journal of Physiology - Endocrinology and Metabolism

Volumn 308, Issue 2, 2015, Pages E130-E143

  Elliott, Amicia D ^a   Ustione, Alessandro ^a   Piston, David W ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclic AMP; Glucagon; Insulin; Pancreatic islets; Somatostatin

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; GLUCAGON; GLUCOSE; INSULIN; PEPTIDES AND PROTEINS; PROTEIN SSTR2 GALPHAI; SOMATOSTATIN; UNCLASSIFIED DRUG; CYCLIC AMP DEPENDENT PROTEIN KINASE;

ANIMAL CELL; ARTICLE; GLUCAGON RELEASE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CONFOCAL MICROSCOPY; CYTOLOGY; FLOW CYTOMETRY; METABOLISM; PANCREAS ISLET; PHYSIOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FLOW CYTOMETRY; GLUCAGON; GLUCAGON-SECRETING CELLS; GLUCOSE; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; SIGNAL TRANSDUCTION; SOMATOSTATIN;

EID: 84921487099     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00344.2014     Document Type: Article

References (45)

1. Ahmad F, Lindh R, Tang Y, Ruishalme I, Ost A, Sahachartsiri B, Strålfors P, Degerman E, Manganiello VC. Differential regulation of adipocyte PDE3B in distinct membrane compartments by insulin and the beta3-adrenergic receptor agonist Cl316243: effects of caveolin-1 knockdown on formation/maintenance of macromolecular signalling complexes. Biochem J424: 399–410, 2009.
2. Beebe SJ, Redmon JB, Blackmore PF, Corbin JD. Discriminative insulin antagonism of stimulatory effects of various cAMP analogs on adipocyte lipolysis and hepatocyte glycogenolysis. J Biol Chem260: 15781–15788, 1985.
3. Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev58: 488–520, 2006.
4. Benninger RK, Head WS, Zhang M, Satin LS, Piston DW. Gap junctions and other mechanisms of cell-cell communication regulate basal insulin secretion in the pancreatic islet. J Physiol589: 5453–5466, 2011.
5. Bramswig NC, Everett LJ, Schug J, Dorrell C, Liu C, Luo Y, Streeter PR, Naji A, Grompe M, Kaestner KH. Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming. J Clin Invest123: 1275–1284, 2013.
6. Cawthorn EG, Chan CB. Effect of pertussis toxin on islet insulin secretion in obese (fa/fa) Zucker rats. Mol Cell Endocrinol75: 197–204, 1991.
7. Chen J, Ostenson CG. Glucagon release is regulated by tyrosine phos-phatase and PI3-kinase activity. Biochem Biophys Res Commun325: 555–560, 2004.
8. Cheng-Xue R, Gomez-Ruiz A, Antoine N, Noel LA, Chae HY, Ravier MA, Chimienti F, Schuit FC, Gilon P. Tolbutamide controls glucagon release from mouse islets differently than glucose: involvement of KATP channels from both alpha-cells and delta-cells. Diabetes62: 1612–1622, 2013.
9. De Marinis YZ, Salehi A, Ward CE, Zhang Q, Abdulkader F, Bengtsson M, Braha O, Braun M, Ramracheya R, Amisten S, Habib AM, Moritoh Y, Zhang E, Reimann F, Rosengren AH, Shibasaki T, Gribble F, Renstrom E, Seino S, Eliasson L, Rorsman P. Glp-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis. Cell Metab11: 543-553, 2010.
10. Degerman E, Ahmad F, Chung YW, Guirguis E, Omar B, Stenson L, Manganiello V. From PDE3B to the regulation of energy homeostasis. Curr Opin Pharmacol11: 676-682, 2011.
11. Diao J, Asghar Z, Chan CB, Wheeler MB. Glucose-regulated glucagon secretion requires insulin receptor expression in pancreatic alpha-cells. J Biol Chem280: 33487-33496, 2005.
12. Dorrell C, Schug J, Lin CF, Canaday PS, Fox AJ, Smirnova O, Bonnah R, Streeter PR, Stoeckert CJ Jr, Kaestner KH, Grompe M. Transcriptomes of the major human pancreatic cell types. Diabetologia 54: 2832-2844, 2011.
13. Dyachok O, Idevall-Hagren O, Sågetorp J, Tian G, Wuttke A, Ar-rieumerlou C, Akusjärvi G, Gylfe E, Tengholm A. Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion. Cell Metab8: 26-37, 2008.
14. Dyachok O, Sågetorp J, Isakov Y, Tengholm A. cAMP oscillations restrict protein kinase A redistribution in insulin-secreting cells. Biochem Soc Trans34: 498-501, 2006.
15. Feniuk W, Jarvie E, Luo J, Humphrey PP. Selective somatostatin sst(2) receptor blockade with the novel cyclic octapeptide, CYN-154806. Neuropharmacology39: 1443-1450, 2000.
16. Franklin I, Gromada J, Gjinovci A, Theander S, Wollheim CB. Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes54: 1808-1815, 2005.
17. Gromada J, Bokvist K, Ding WG, Barg S, Buschard K, Renström E, Rorsman P. Adrenaline stimulates glucagon secretion in pancreatic A-cells by increasing the Ca2+ current and the number of granules close to the L-type Ca2+ channels. J Gen Physiol110: 217-228, 1997.
18. Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev28: 84-116, 2007.
19. Hatakeyama H, Takahashi N, Kishimoto T, Nemoto T, Kasai H. Two cAMP-dependent pathways differentially regulate exocytosis of large dense-core and small vesicles in mouse beta-cells. J Physiol582: 1087-1098, 2007.
20. Hauge-Evans AC, King AJ, Carmignac D, Richardson CC, Robinson IC, Low MJ, Christie MR, Persaud SJ, Jones PM. Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes58: 403-411, 2009.
21. Hauge-Evans AC, King AJ, Fairhall K, Persaud SJ, Jones PM. A role for islet somatostatin in mediating sympathetic regulation of glucagon secretion. Islets2: 341-344, 2010.
22. Idevall-Hagren O, Barg S, Gylfe E, Tengholm A. cAMP mediators of pulsatile insulin secretion from glucose-stimulated single beta-cells. J Biol Chem285: 23007-23018, 2010.
23. Jarrousse C, Rosselin G. Regulation by glucose and cyclic nucleotides of the glucagon and insulin release induced by amino acids. Diabete Metab1: 135-142, 1975.
24. Kailey B, Van De Bunt M, Cheley S, Johnson PR, Macdonald PE, Gloyn AL, Rorsman P, Braun M. SSTR2 is the functionally dominant somatostatin receptor in human pancreatic fj- and a-cells. Am J Physiol Endocrinol Metab303: E1107-E1116, 2012.
25. Katakami N, Kim YS, Kawamori R, Yamasaki Y. The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial. Circulation121: 2584-2591, 2010.
26. Kawamori D, Kurpad AJ, Hu J, Liew CW, Shih JL, Ford EL, Herrera PL, Polonsky KS, Mcguinness OP, Kulkarni RN. Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab9: 350-361, 2009.
27. Klarenbeek JB, Goedhart J, Hink MA, Gadella TW, Jalink K. A mTurquoise-based cAMP sensor for both FLIM and ratiometric read-out has improved dynamic range. PLoS One6: e19170, 2011.
28. Koh DS, Cho JH, Chen L. Paracrine interactions within islets of lang-erhans. J Mol Neurosci48: 429-440, 2012.
29. Lam AJ, St-Pierre F, Gong Y, Marshall JD, Cranfill PJ, Baird MA, McKeown MR, Wiedenmann J, Davidson MW, Schnitzer MJ, Tsien RY, Lin MZ. Improving FRET dynamic range with bright green and red fluorescent proteins. Nat Methods9: 1005-1012, 2012.
30. Le Marchand SJ, Piston DW. Glucose decouples intracellular Ca2+ activity from glucagon secretion in mouse pancreatic islet alpha-cells. PLoS One7: e47084, 2012.
31. Le Marchand SJ, Piston DW. Glucose suppression of glucagon secretion: metabolic and calcium responses from alpha-cells in intact mouse pancreatic islets. J Biol Chem285: 14389-14398, 2010.
32. Liang L, Beshay E, Prud’homme GJ. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice. Diabetes47: 570-575, 1998.
33. Niswender KD, Postic C, Jetton TL, Bennett BD, Piston DW, Efrat S, Magnuson MA. Cell-specific expression and regulation of a glucokinase gene locus transgene. J Biol Chem272: 22564-22569, 1997.
34. Ravier MA, Rutter GA. Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells. Diabetes54: 1789-1797, 2005.
35. Rocheleau JV, Walker GM, Head WS, McGuinness OP, Piston DW. Microfluidic glucose stimulation reveals limited coordination of intracellular Ca2+ activity oscillations in pancreatic islets. Proc Natl Acad Sci USA101: 12899-12903, 2004.
36. Schwetz TA, Ustione A, Piston DW. Neuropeptide Y and somatostatin inhibit insulin secretion through different mechanisms. Am J Physiol Endocrinol Metab304: E211-E221, 2013.
37. Strowski MZ, Parmar RM, Blake AD, Schaeffer JM. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology141: 111-117, 2000.
38. Tian G, Sandler S, Gylfe E, Tengholm A. Glucose- and hormone-induced cAMP oscillations in alpha- and beta-cells within intact pancreatic islets. Diabetes60: 1535-1543, 2011.
39. Vaeth M, Schliesser U, Müller G, Reissig S, Satoh K, Tuettenberg A, Jonuleit H, Waisman A, Müller MR, Serfling E, Sawitzki BS, Ber-berich-Siebelt F. Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3 + regulatory T cells. Proc Natl Acad Sci USA109: 16258-16263, 2012.
40. Vikram A, Jena G. S961, an insulin receptor antagonist causes hyperin-sulinemia, insulin-resistance and depletion of energy stores in rats. Biochem Biophys Res Commun398: 260-265, 2010.
41. Vollert S, Kaessner N, Heuser A, Hanauer G, Dieckmann A, Knaack D, Kley HP, Beume R, Weiss-Haljiti C. The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db/db mice. Diabetologia55: 2779-2788, 2012.
42. Xu E, Kumar M, Zhang Y, Ju W, Obata T, Zhang N, Liu S, Wendt A, Deng S, Ebina Y, Wheeler MB, Braun M, Wang Q. Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab3: 47-58, 2006.
43. Yue JT, Burdett E, Coy DH, Giacca A, Efendic S, Vranic M. Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats. Diabetes61: 197-207, 2012.
44. Zhang Q, Ramracheya R, Lahmann C, Tarasov A, Bengtsson M, Braha O, Braun M, Brereton M, Collins S, Galvanovskis J, Gonzalez A, Groschner LN, Rorsman NJ, Salehi A, Travers ME, Walker JN, Gloyn AL, Gribble F, Johnson PR, Reimann F, Ashcroft FM, Rorsman P. Role Of Katp channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes. Cell Metab18: 871– 882, 2013.
45. Zmuda-Trzebiatowska E, Oknianska A, Manganiello V, Degerman E. Role Of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes. Cell Signal18: 382-390, 2006.